12
Participants
Start Date
July 28, 2021
Primary Completion Date
December 18, 2024
Study Completion Date
December 18, 2024
wilate
wilate is a plasma-derived, stable, highly purified, double virus inactivated concentrate of freeze-dried active VWF and factor VIII (FVIII) prepared from cryoprecipitate and intended for the treatment of patients with von Willebrand disease (VWD) and/or haemophilia A
Tulane University, New Orleans
University Hospital Ostrava Department for Pediatric Medicine, Ostrava
University Hospital Motol, Department of Paediatric Haematology and Oncology, Prague
Gerinnungszentrum Rhein-Ruhr Ambulanz und Fachlaboratorium für Gerinnungserkrankungen/Hämophilie, Duisburg
IMSP Mother and Child Institute, Chisinau
PHI University Clinic for Child Diseases, Skopje
FSBI National Research Medical Center of Pediatric Hematology, Oncology and Immunology, Moscow
Morozovskaya Children's Hospital, Moscow
"Danylo Halytsky Lviv National Medical University, Communal Institution of Lviv Regional Council Western Ukrainian Specialized Children's Medical Centre", Lviv
Lead Sponsor
Octapharma
INDUSTRY